BioPharmaceutical glossaries & taxonomies newest definitions

You are here > Biopharmaceutical Glossary Homepage/Search Index > Newest biopharmaceutical definitions

Newest biopharmaceutical definitions
Evolving Terminologies for Emerging Technologies
Comments? Questions? Revisions? Mary Chitty mchitty@healthtech.com
Last revised July 13, 2010
View a Printer-Friendly Version of this Web Page!

New Page 1

Please register for CHI's Genomics Glossaries & Taxonomies website. This sign-in box with then disappear from each page, if you accept cookies. Use of this site will continue to be free, but better demographic data on who is accessing this material helps us to justify the expense of maintaining this resource. Registration policy has details. Registered users of the Genomics Glossaries & Taxonomies will automatically be signed up for CHI's complimentary email monthly newsletter, GenomeLink, unless you choose to opt out of receiving it.
	Mr. Ms. Mrs. Dr. Prof.
First:		Last:
Title:		Dept.:
Company:
Address:
City:
State:	Zip:
Country:
Email:
Opt-out of Email	YES NO
Telephone:
	Would you like to receive CHI event updates via fax? Yes No
Fax:

21st century Drug discovery & development Map Informatics map Technologies map Biology & chemistry map Finding guide to terms in these glossaries Site Map
** newest of the new definitions

accelerator mass spectrometry: Mass spectrometry

adaptive clinical trials: Drug approvals and clinical trials

Bayesian clinical trials: Drug approvals and clinical trials

biological chemistry: Chemistry (& biology)

biomarker guidelines: Biomarkers

biomathematics Algorithms

biomedical polymers: Biomaterials

biomolecular screening: Assays & screening

cell specific biomarkers: Biomarkers

cellular dielectric spectroscopy CDS: Technologies

chaperome: -Omes & -omics

Clinical Trial Design Task Force: Clinical Trials

combination therapies: Drug Discovery & Development

**comparative effectiveness research: Research

comparative systems biology: Genomic Manipulation & Disruption

computational physiology: In Silico & Molecular Modeling

computational sensing: Labels Signaling & detection

**connectome: -Omes & -omics

Copy Number Polymorphisms CNPs: SNPs and Genetic Variations

developability: Drug discovery & development

diffusion tensor imaging: Molecular imaging

disproportionate drug metabolite: Drug safety, Pharmacovigilance & toxicology

drug metabolism: Pharmacogenomics

e-health: http://en.wikipedia.org/wiki/EHealth

eSNPs expression SNPs: SNPs and genetic variations

evidence based toxicology: Drug safety, Pharmacovigilance & toxicology

exploratory IND: Drug approvals

expressomics: -Omes & -omics

follow-on drug: Drug discovery & development

fragment based drug discovery Assays and screening

genetic susceptibility: Molecular diagnostics -- genetic & genomic testing

GIS Geographic Information Systems: Molecular Medicine and Diagnostics

**glycomimetics: Glycosciences

green chemistry: Chemistry & biology

GWAS Genome Wide Association Sequencing: Sequencing

**health disparities: Molecular Medicine

human induced pluripotent stem cells hiPS: Stem cells

inflammasome: -Omes & -omics

integrative and organ systems pharmacology: Pharmacogenomics

** in vitro adventitious assays: Assays & screening

in vitro diagnostic multivariate index assays IVDMIAs: Genetic & genomic testing

integrative biology: Pharmaceutical biology

kidney safety biomarkers: Biomarkers

label free detection: Labels Signaling & detection

lead hopping: Assays

mass spectrometry" IUPAC Mass Spectrometry Standard definitions of terms relating to mass spectrometry Provisional recommendations, 2006 http://www.iupac.org/reports/provisional/abstract06/murray_prs.pdf

materials chemistry: Chemistry & biology

medical resequencing: Sequencing

mesoscopic biology: Expression genes & proteins

metabolite: Drug safety, Pharmacovigilance & toxicology

microdosing Pharmacogenomics

microtissues: Cell biology

mitochondriomics: -Omes & -omics

molecular biosensors: Labels Signaling & detection

molecular crowding: Biomolecules

molecular electronics: Nanoscience & miniaturization

molecular events: Cancer diagnostics, genomics, prognostics & therapeutics

molecular pharmacology Pharmacogenomics

mRNA biomarkers: Biomarkers

nanolabels: Labels Signaling & detection

nanomedicine: Nanoscience & miniaturization

nanotechnology in the clinical laboratory setting: Molecular Medicine

natural competence: DNA

network pharmacology: Pharmacogenomics

next generation sequencing: Sequencing

niche busters: Drug discovery & development

-Omes & -omics: Lots of new terms including alleome, chromatinomics, chromosonics, cryobionomics, embryogenomics, epitomics, fragonomics, lectinomics, mitogenomics, Nobonomics, paleogenomics, RNome, RNomics, separomics, strainomics, transgenomics

oncolytic: Cancer diagnostics, genomics, prognostics & therapeutics

patient engagement: Molecular Medicine

patient navigation: Cancer diagnostics, genomics, prognostics & therapeutics

pharmacokinetics: Pharmacogenomics

pharmacological biomarkers: Biomarkers

pharmacologically active metabolite: Drug safety, Pharmacovigilance & toxicology

Phase II clinical trial design: Clinical Trials

Phase zero, Phase O: Drug approvals

physiologically based pharmacodynamics: Pharmacogenomics

pipeline problem: Drug discovery

post-genomic chemistry: Chemistry & biology

preclinical safety biomarkers: Biomarkers